Monoclonal antibodies to progastrin

Details for Australian Patent Application No. 2005286164 (hide)

Owner Cancer Advances Inc.

Inventors Grimes, Stephen

Agent Spruson & Ferguson

Pub. Number AU-B-2005286164

PCT Pub. Number WO2006/032980

Priority 60/612,224 22.09.04 US

Filing date 21 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 24 May 2012

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/26 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/032980 Priority application(s): WO2006/032980

5 July 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read Monoclonal antibodies to progastrin

24 September 2009 Assignment before Grant

  Receptor Biologix, Inc. The application has been assigned to Cancer Advances Inc.

24 May 2012 Application Accepted

  Published as AU-B-2005286164

20 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286166-Coated abrasive materials and method of manufacture

2005286161-Stabilized leukotriene B4 (LTB4) agent pharmaceutical